Tags
Ceramtec, Food & Drug Administration, hip, Hip Replacement, Orthopedic surgery, Smith & Nephew, surgery, UNited States
Smith & Nephew Receives US FDA Approval For Ceramic-On-Ceramic Hip
June 25, 2006
By: Victor Rocha
Website: http://www.hip-replacement-care.com
Smith & Nephews’ Orthopaedics division today announced the US Food and Drug Administration‘s approval of its newest advanced bearing product for patients who undergo total hip replacement surgery, the ceramic-on-ceramic hip. Smith & Nephew will immediately launch the product as an extension of its Reflection family of hip implants.
The approval and introduction of the ceramic-on-ceramic product complements the company’s existing line of advanced bearing products for hip replacement surgery, including a hip product made of oxidized zirconium metal, branded OXINIUM*. Advanced bearing materials are longer wearing and are increasingly used by orthopaedic surgeons to treat younger or more active patients.
“Smith & Nephew Orthopaedics strategy is to become the only orthopaedic company which offers a full range of advanced bearing products for both hips and knees, bringing real choice to surgeons and patients in the United States,” said Orthopaedics President, David Illingworth. “With OXINIUM*, ceramic-on-ceramic, and our metal-on-metal hip product which is already available outside the US, we are leading the way in technological innovation in the hip segment.”
The Reflection Ceramic Acetabular System was approved by the FDA as a Pre-Market Approval (PMA) process using the company’s own clinical data. The ceramic components will be manufactured for Smith & Nephew by Ceramtec.
“Smith & Nephew’s Reflection Cup system has innovated in the hip market for nearly ten years. The introduction of the ceramic bearings in the Reflection system now offers market leading performance in both range of motion and the avoidance of impingement,” said Steve Hirsch, Senior Vice President and General Manager of the Reconstructive Division.
Hip replacement devices are designed to replace and replicate the function of a ball-and-socket hip joint. Patients requiring hip replacement surgery have usually been afflicted with either osteoarthritis or some form of degenerative joint disease. In the U.S., surgeons perform nearly 350,000 hip replacements a year.
About The Author:
Victor Rocha is a successful author and regular contributor to http://www.hip-replacement-care.com. Information on hip replacement; the cause, diagnosis, symptoms, surgery and treatment for recovery and rebuilding your body.
Related articles
- ANALYSIS OF BEARING-SURFACE-RELATED COMPLICATIONS [Hip] (earlsview.com)
- Associate Professor Michael J. Neil – Doesn’t Recommend Resurfacing (earlsview.com)
- Fast Track Discharge Following Hip Replacement (earlsview.com)
Pingback: Ceramic Hip Joint Replacement Devices « Earl's View
Pingback: Squeaking Ceramic Hips – Why? « Earl's View
Pingback: Sadwin Raises More Questions – Will They Ever Be Answered? « Earl's View
Pingback: Creating a longer-lasting hip for patients « Earl's View
Pingback: Biomet Receives FDA Clearance for Active Articulation(TM) E1(R) Dual Mobility Hip System « Earl's View
Pingback: Squeaky Ceramic Hip Implants… « Earl's View
Pingback: Visit to the Surgeon Monday 18th July 2011 « Earl's View
Pingback: Smith & Nephew’s Exclusive OXINIUM Material for Hip Replacement Implants Chosen for Premium Reimbursement in Japan « Earl's View
Pingback: The Hip Story Continues « Earl's View
Pingback: Industry News – OXINIUM (Oxidized Zirconium) and cross-linked polyethylene (XLPE) « Earl's View
Pingback: History – Smith & Nephew Knee Implant Recall – 2003; Oxinium « Earl's View
Pingback: History – Smith & Nephew Hip Component Mislabelled – 2007 « Earl's View
Pingback: History – Smith & Nephew Hip Resurfacing Cups Recalled 2007 « Earl's View
Pingback: Is Oxinium Going to be Safer? Maybe? « Earl's View
Pingback: Ceramic-on-Metal Total Hip Replacement « Earl's View
Pingback: US arthroscopy market to double by 2017, to over $4.2 billion « Earl's View
Pingback: Corin Cormet FDA Approval – At Least the FDA Panel included Metal Ion Serum Levels « Earl's View
Pingback: Corin Cormet Presentation to FDA Approvals Panel « Earl's View
Pingback: Analysis of squeaking on ceramic hip endoprosthesis using the complex eigenvalue method « Earl's View
Pingback: Recent Knee Replacement Success « Earl's View
Pingback: How ‘Bout Smith & Nephew « Earl's View
Pingback: Economic Sense at Smith & Nephew But will it improve things for Patients? « Earl's View
Pingback: Maryland – State’s health care professionals got millions in consulting fees « Earl's View
Pingback: Howard Sadwin’s Story – a lesson in perserverance… « Earl's View